ILLUSIO

ILLUSIO

Early Stage

The world's first augmented reality platform for cosmetic surgery

The world's first augmented reality platform for cosmetic surgery

Overview

Raised to Date: Raised: $227,210

Total Commitments ($USD)

Platform

Equifund

Start Date

02/24/2020

Close Date

04/30/2020

Min. Goal
$20,000
Max. Goal
$1,070,000
Min. Investment

$700

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.09

Pre-Money Valuation

$15,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

05/02/2020

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$3,496

# of Investors

189

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2015

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

San Clemente, California

Business Type

Growth

Illusio, the world’s first augmented reality platform for cosmetic surgery, is raising funds on Equifund Crowd Funding Portal. The company has a pre-money valuation of $15 million and owns a state-of-the-art patented technology that increases the visualization for procedures like liposuction and breast implants. Using Illusio technology, the doctors can present real-time three-dimensional visualizations to patients. Illusio was founded by Ethan Winner, Kyle Song M.D., and Preston Platt. The current round of crowdfunding of Illusio has a minimum raise of $20,000 and a maximum raise of $1,070,000, and the funds will be used towards marketing, advertising, leasing costs, repayment of indebtedness, and general working capital. Illusio has a strategic partnership with Mentor Worldwide, a global brand in breast implants.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$3,400

$0

COGS

$-125,857

$-179,904

Tax

$800

$800

 

 

Net Income

$-607,030

$-523,493

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$163,388

$54,005

Accounts Receivable

$0

$0

Total Assets

$166,235

$54,005

Short-Term Debt

$0

$1,149

Long-Term Debt

$0

$0

Total Liabilities

$0

$1,149

Financials as of: 02/24/2020
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
ILLUSIO 06/21/2021 Self Managed - $350,000 SAFE Funded RegD 506(b)
ILLUSIO 04/29/2020 Equifund $15,000,000 $227,210 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
ILLUSIO on Equifund CFP
Platform: Equifund
Security Type: Equity - Common
Valuation: $15,000,000
Price per Share: $1.09

Follow company

Follow ILLUSIO on Equifund CFP

Buy ILLUSIO's Deal Report

Warning: according to the close date for this deal, ILLUSIO may no longer be accepting investments.

ILLUSIO Deal Report

Get KingsCrowd’s comprehensive report on ILLUSIO including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether ILLUSIO is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the ILLUSIO deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge